AIGEN Sciences is an AI-first drug discovery company building an end-to-end platform spanning target discovery, drug design, and clinical trial planning. By combining agent-based LLM systems with experimental execution, AIGEN focuses on AI that drives real therapeutic programs rather than isolated predictions or tools.